[1] CORYELL PR, DIEKMAN BO, LOESER RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47-57.
[2] CHEN L, ZHENG JJY, LI G, et al. Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading. J Orthop Translat. 2020;24:66-75.
[3] MASON D, ENGLUND M, WATT FE. Prevention of posttraumatic osteoarthritis at the time of injury: Where are we now, and where are we going? J Orthop Res. 2021;39(6):1152-1163.
[4] RAMASAMY B, MAGNE F, TRIPATHY SK, et al. Association of Gut Microbiome and Vitamin D Deficiency in Knee Osteoarthritis Patients: A Pilot Study. Nutrients. 2021;13(4):1272.
[5] KULKARNI P, MARTSON A, VIDYA R, et al. Pathophysiological landscape of osteoarthritis. Adv Clin Chem. 2021;100:37-90.
[6] WANG R, XU B. TGF-beta1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6. Cell Tissue Res. 2021;384(1):113-127.
[7] CHU L, LIU X, HE Z, et al. Articular Cartilage Degradation and Aberrant Subchondral Bone Remodeling in Patients with Osteoarthritis and Osteoporosis. J Bone Miner Res. 2020; 35(3):505-515.
[8] HAN D, FANG Y, TAN X, et al. The emerging role of fibroblast-like synoviocytes-mediated synovitis in osteoarthritis: An update. J Cell Mol Med. 2020;24(17): 9518-9532.
[9] ZHANG H, CAI D, BAI X. Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage. 2020; 28(5):555-561.
[10] HU W, CHEN Y, DOU C, et al. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis. 2020;80(4):413-422.
[11] QIAO L, LI Y, SUN S. Insulin Exacerbates Inflammation in Fibroblast-Like Synoviocytes. Inflammation. 2020;43(3):916-936.
[12] YOSHITOMI H. Regulation of Immune Responses and Chronic Inflammation by Fibroblast-Like Synoviocytes. Front Immunol. 2019;10:1395.
[13] ZHANG G, GU M, XU Y, et al. A comprehensive analysis on the effects of 1,25(OH)2D3 on primary chondrocytes cultured from patients with osteoarthritis. Gene. 2020;730:144322.
[14] AMINI KADIJANI A, BAGHERIFARD A, MOHAMMADI F, et al. Association of Serum Vitamin D with Serum Cytokine Profile in Patients with Knee Osteoarthritis. Cartilage. 2021:19476035211010309.
[15] SUN HQ, YAN D, WANG QN, et al. 1,25-Dihydroxyvitamin D3 attenuates disease severity and induces synoviocyte apoptosis in a concentration-dependent manner in rats with adjuvant-induced arthritis by inactivating the NF-kappaB signaling pathway. J Bone Miner Metabol. 2019;37(3):430-440.
[16] GU X, GU B, LV X, et al. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes. Cell Death Dis. 2016;7(10):e2423.
[17] FENG X, LV C, WANG F, et al. Modulatory effect of 1,25-dihydroxyvitamin D3 on IL1 beta -induced RANKL, OPG, TNF alpha , and IL-6 expression in human rheumatoid synoviocyte MH7A. Clin Dev Immunol. 2013;2013:160123.
[18] DANKERS W, GONZALEZ-LEAL C, DAVELAAR N, et al. 1,25(OH)2D3 and dexamethasone additively suppress synovial fibroblast activation by CCR6(+) T helper memory cells and enhance the effect of tumor necrosis factor alpha blockade. Arthrit Res Ther. 2018;20(1):212.
[19] QIN Q, LIU H, SHOU J, et al. The inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases. Cell Mol Immunol. 2021; 18(4):992-1004.
[20] AN S, HU H, LI Y, et al. Pyroptosis Plays a Role in Osteoarthritis. Aging Dis. 2020; 11(5):1146-1157.
[21] ZHAO LR, XING RL, WANG PM, et al. NLRP1 and NLRP3 inflammasomes mediate LPS/ATPinduced pyroptosis in knee osteoarthritis. Mol Me Rep. 2018;17(4):5463-5469.
[22] ZU Y, MU Y, LI Q, et al. Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. J Orthop Surg Res. 2019;14(1):307.
[23] XIN L, CHE B, ZHAI B, et al. 1,25-Dihydroxy Vitamin D3 Attenuates the Oxidative Stress-Mediated Inflammation Induced by PM2.5via the p38/NF-kappaB/NLRP3 Pathway. Inflammation. 2019;42(2):702-713.
[24] CARLBERG C. Vitamin D Signaling in the Context of Innate Immunity: Focus on Human Monocytes. Front Immunol. 2019;10:2211.
[25] ZHANG H, KHOA LTP, MAO F, et al. MLL1 Inhibition and Vitamin D Signaling Cooperate to Facilitate the Expanded Pluripotency State. Cell Rep. 2019;29(9): 2659-2671.e2656.
[26] ZHANG Z, HUANG C, JIANG Q, et al. Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition). Ann Trans Med. 2020;8(19):1213.
[27] DE LANGE-BROKAAR BJ, IOAN-FACSINAY A, VAN OSCH GJ, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage. 2012;20(12):1484-1499.
[28] LIU S, CAO C, ZHANG Y, et al. PI3K/Akt inhibitor partly decreases TNF-alpha-induced activation of fibroblast-like synoviocytes in osteoarthritis. J Orthop Surg Res. 2019;14(1):425.
[29] ROEMER FW, GUERMAZI A, HUNTER DJ, et al. The association of meniscal damage with joint effusion in persons without radiographic osteoarthritis: the Framingham and MOST osteoarthritis studies. Osteoarthritis Cartilage. 2009; 17(6):748-753.
[30] BENITO MJ, VEALE DJ, FITZGERALD O, et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005;64(9):1263-1267.
[31] YANG CR, SHIH KS, LIOU JP, et al. Denbinobin upregulates miR-146a expression and attenuates IL-1beta-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytes. J Mol Med. 2014;92(11):1147-1158.
[32] CARLBERG C, MUNOZ A. An update on vitamin D signaling and cancer. Semin Cancer Biol. 2020.S1044-579X(20)30114-0.
[33] MALLUCHE HH, HENRY H, MEYER-SABELLAK W, et al. Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone. Am J Physiol. 1980;238(5):E494-498.
[34] KELLEY N, JELTEMA D, DUAN Y, et al. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019;20(13):3328.
[35] RATHINAM VA, FITZGERALD KA. Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell. 2016;165(4):792-800.
[36] SUTTERWALA FS, HAASKEN S, CASSEL SL. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci. 2014;1319(1):82-95.
[37] CAO R, MA Y, LI S, et al. 1,25(OH)2 D3 alleviates DSS-induced ulcerative colitis via inhibiting NLRP3 inflammasome activation. J Leukoc Biol. 2020;108(1):283-295.
[38] TULK SE, LIAO KC, MURUVE DA, et al. Vitamin D(3) metabolites enhance the NLRP3-dependent secretion of IL-1beta from human THP-1 monocytic cells. J Cell Biochem. 2015;116(5):711-720.
[39] POLI G, FABI C, BELLET MM, et al. Epigenetic Mechanisms of Inflammasome Regulation. Int J Mol Sci. 2020;21(16):5758.
[40] LECOEUR H, PRINA E, ROSAZZA T, et al. Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-kappaB/NLRP3-Mediated Inflammatory Response. Cell Rep. 2020;30(6):1870-1882.e1874.
[41] LECOEUR H, ROSAZZA T, KOKOU K, et al. Leishmania amazonensis Subverts the Transcription Factor Landscape in Dendritic Cells to Avoid Inflammasome Activation and Stall Maturation. Front Immunol. 2020;11:1098.
[42] UCKELMANN M, SIXMA TK. Histone ubiquitination in the DNA damage response. DNA Rep. 2017;56:92-101.
[43] CHAN HL, MOREY L. Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer. Trends Biochem Sci. 2019;44(8):688-700.
[44] BARBOUR H, DAOU S, HENDZEL M, et al. Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes. Nat Commun. 2020;11(1):5947.
[45] FU B, WANG H, WANG J, et al. Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification. PloS One. 2013;8(4):e61423.
|